- Home
- BURL vs ROIV Comparison
BURL vs ROIV Comparison
Compare BURL & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BURL | ROIV |
|---|---|---|
| Founded | 1972 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | 750 |
| Industry | Department/Specialty Retail Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.4B | 21.0B |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BURL | ROIV |
|---|---|---|
| Price | $286.36 | $28.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 9 |
| Target Price | ★ $355.29 | $28.94 |
| AVG Volume (30 Days) | 544.9K | ★ 4.4M |
| Earning Date | 05-28-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.92 | N/A |
| EPS | ★ 9.51 | N/A |
| Revenue | ★ $11,566,910,000.00 | $29,053,000.00 |
| Revenue This Year | $12.72 | N/A |
| Revenue Next Year | $8.47 | $744.61 |
| P/E Ratio | $30.58 | ★ N/A |
| Revenue Growth | ★ 8.76 | N/A |
| 52 Week Low | $223.27 | $10.71 |
| 52 Week High | $351.85 | $30.33 |
Technical Indicators
Market Signals| Indicator | BURL | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 32.55 | 47.09 |
| Support Level | $257.09 | $27.00 |
| Resistance Level | $312.84 | $30.10 |
| Average True Range (ATR) | 8.96 | 0.87 |
| MACD | -2.52 | -0.02 |
| Stochastic Oscillator | 16.31 | 33.11 |
Price Performance
Historical ComparisonAbout BURL Burlington Stores Inc.
Burlington Stores Inc is an off-price retailer offering an extensive selection of in-season, fashion-focused merchandise, including women's ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts, and coats. The company sells a broad selection of desirable, first-quality, current-brand, labeled merchandise acquired directly from nationally recognized manufacturers and other suppliers. It sells products in categories such as Ladies apparel, Accessories and shoes, Home, Mens apparel, Kids apparel and baby, and Outerwear.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.